Entrada Therapeutics Inc (TRDA) Stock Price, Quote, News & History

TRDANASDAQ
$6.38
-0.45-6.59%
At close: May 15, 5:00 PM EST
$6.38
N/A
After Hours: May 15, 4:00 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-131.70M
Investing Cash Flow (TTM)
139.01M
Financing Cash Flow (TTM)
637.00K
Free Cash Flow (TTM)
-131.64M
Capital Expenditure (TTM)
59.00K
Net Change in Cash (TTM)
7.95M

Analyst Trends and Forecast

2
Feb
1
Apr
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$217.48M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
49.44
PB Ratio (TTM)
0.98
Earnings Yield % (TTM)
-58.61%
Earnings Yield % (FWD)
-57.88%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$6.97

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$76.44M
Debt to Equity
0.18
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$6.66
Close
$6.38
Volume / Avg.
327.12K / 332.77K
Day Range
$6.31 - $6.76
52 Wk Range
4.93 - 16.45
Market Cap
$247.68M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
27
Short Interest
4%
Days to Cover
5.48

About

Sector
Health Care
Industry
Biotechnology
Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's E...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Entrada Therapeutics (TRDA) stock?

A

You can purchase shares of Entrada Therapeutics (NASDAQ:TRDA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Entrada Therapeutics (TRDA) competitors?

A

There are no as such competitors for Entrada Therapeutics.

Q

What is the forecast, or price target, for Entrada Therapeutics (TRDA) stock?

A

Entrada Therapeutics has a consensus price target of $23.50.

Q

What is the current price for Entrada Therapeutics (TRDA)?

A

The stock price for Entrada Therapeutics (NASDAQ: TRDA) is $6.38 last updated May 15, 2026 at 4:00 PM EDT.

Q

Does Entrada Therapeutics (TRDA) pay a dividend?

A

There are no upcoming dividends for Entrada Therapeutics.

Q

When is Entrada Therapeutics (NASDAQ:TRDA) reporting earnings?

A

Entrada Therapeutics does not have any upcoming earnings scheduled.

Q

Is Entrada Therapeutics (TRDA) going to split?

A

There is no upcoming split for Entrada Therapeutics.

Q

What sector and industry does Entrada Therapeutics (TRDA) operate in?

A

Entrada Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.